A staged approach with vincristine, adriamycin, and dexamethasone followed by bortezomib, thalidomide, and dexamethasone before autologous hematopoietic stem cell transplantation in the treatment of newly diagnosed multiple myeloma

Bortezomib-based regimens have significant activities in multiple myeloma (MM). In this study, we tested the efficacy of a total therapy with a staged approach where newly diagnosed MM patients received vincristine/adriamycin/dexamethsone (VAD). VAD-sensitive patients (≥75% paraprotein reduction) re...

Descripción completa

Detalles Bibliográficos
Autores principales: Chim, C. S., Lie, A. K. W., Chan, E. Y. T., Leung, Y. Y., Cheung, S. C. W., Chan, S. Y. T., Liang, Raymond, Kwong, Y. L.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924968/
https://www.ncbi.nlm.nih.gov/pubmed/20428873
http://dx.doi.org/10.1007/s00277-010-0959-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2924968/
https://www.ncbi.nlm.nih.gov/pubmed/20428873
http://dx.doi.org/10.1007/s00277-010-0959-4

Ejemplares similares